ArticleTranslational lung cancer research2022

Comparison of perioperative outcomes among non-small cell lung cancer patients with neoadjuvant immune checkpoint inhibitor plus chemotherapy, EGFR-TKI, and chemotherapy alone: a real-world evidence study.

Deping Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.